Table 1 Details of included studies
Study | Location | Database and study duration | Diagnosis of PTDM | Group | Sample size | Mean age (years) | Male gender (%) | PD prior to transplant (%) | Dialysis duration (months) | Living donor (%) | Tarcolimus therapy (%) | Follow-up | NOS score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yeh 2020 [17] | Taiwan | Taiwan National Health Insurance Research Database (1997–2011) | Using ICD codes | PTDM No-DM | 631 2501 | 50.62 43.15 | 53.7 47.8 | 6.2 8.5 | NR | NR | 69.1 76.8 | Mean 5.19 to 7.77 years | 8 |
Aleksic 2020 [28] | USA | Montefiore Health System (2012–2014) | ADA criteria | PTDM No-DM | 58 92 | 56 47.4 | 62.1 57.6 | NR | NR | 10.3 25 | NR | Median 45.5 months | 8 |
Dienemann 2016 [16] | USA | University of Pennsylvania (1996–2012) | ADA criteria | PTDM No-DM | 447 980 | 51.5 46.3 | 60.2 56.2 | NR | 27.4 ± 33.9 27.8 ± 37.1 | 32 38.2 | 89.5 89.2 | Mean 6.8 to 7.4 years | 8 |
Lv 2014 [27] | China | Zhongshan Hospital (1993–2008) | ADA criteria | PTDM No-DM | 87 341 | 45.6 38.9 | 69 66.9 | 5.7 8.8 | 35.3 ± 44.7 28.7 ± 36.6 | 9.2 27 | NR | Up to 10 years | 8 |
Wauters 2012 [15] | USA | Mayo clinic, Rochester (1984–2008) | ADA criteria | PTDM No-DM | 154 992 | NR | NR | NR | NR | NR | NR | Mean 90.4 months | 8 |
Norway | Oslo University Hospital (1995–2006) | ADA criteria | PTDM No-DM | 245 637 | 56 49 | 65 62 | NR | 15 ± 10 15 ± 14 | 33 51 | 13 9 | Median 6 years | 8 | |
Tsai 2011 [31] | Taiwan | Chung Shan Medical University Hospital (1999–2008) | ADA criteria | PTDM No-DM | 104 253 | 55.4 52.4 | 56.7 49.8 | 14.4 17.4 | 23 ± 29.2 28.8 ± 32.9 | NR | 82.7 76.3 | Mean 70.3 to 74 months | 8 |
Kuo 2010 [32] | USA | Organ Procurement and Trans- plant Network/United Network for Organ Sharing (OPTN/UNOS) database (2004–2007) | Using ICD codes | PTDM No-DM | 2104 20,964 | 52.9 47.5 | 62.9 58.3 | NR | NR | 34.4 43.8 | 82.5 78.6 | Median 548 days | 7 |
Demirci 2010 [23] | Turkey | Ege university school of medicine (1989–2003) | ADA criteria | PTDM No-DM | 102 453 | 36 30.8 | 56.9 64.3 | NR | 27 ± 28 20 ± 23 | 68.6 74.6 | NR | Up to 10 years | 8 |
Cole 2008 [18] | Canada | US renal data system (1995–2002) | Using ICD codes | PTDM No-DM | 2598 25,109 | NR | NR | NR | NR | NR | NR | Up to 10 years | 8 |
Gonzalez-Posada 2006 [24] | Spain | NR (1990, 1994 and 1998) | National diabetes data group 1979 criteria | PTDM No-DM | 251 2958 | 42.9 39.8 | 56.2 63 | NR | 34.6 ± 38 43.3 ± 46.9 | NR | NR | 3 years | 8 |
Kasiske 2003 [25] | USA | US renal data system (1996–2000) | Using ICD codes | PTDM No-DM | 2798 8861 | NR | NR | NR | NR | NR | NR | Up to 3 years | 8 |
Cosio 2002 [26] | USA | Ohio State University (1993–1997) | Transplanted patients who previously were not diabetic required treatment of hyperglycemia with either oral hypoglycemic agents and/or insulin | PTDM No-DM | 293 1186 | 48 40 | 63 58 | NR | NR | NR | NR | Up to 10 years | 8 |